Psoriasis kliniske forsøg i Michigan
4 studier for Psoriasis søger deltagere på steder i Michigan.
Officiel studietekst (engelsk)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
- LEO Pharma Investigational Site, West Bloomfield
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07013201A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- David Fivenson, MD, PLC, Ann Arbor
- The Derm Institute of West Michigan, Caledonia
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- C.S. Mott Clinical Research Center (CRC), Detroit
- Henry Ford Medical Center, Detroit
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT06979453A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- Ppp001 50757, Auburn Hills
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT07219420Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.